Study Operations Manager

We are inviting applications to join our EMEA Clinical Operations team as a

Study Operations Manager I/II, home-based.

Permanent, full-time.

Single sponsor dedicated to a worldwide biopharmaceutical company that relentlessly seeks breakthroughs to improve patients’ lives. Their daily innovation contributes to a healthier global community. This is where today’s visionaries, solution-seekers, and trailblazers converge to shape tomorrow’s groundbreaking solutions. Together, we have the power to revolutionize patients’ well-being. Every choice and step we make is guided by our unwavering focus on patients, fostering an environment where innovation thrives.

The Study Operations Manager I (SOM I) has responsibilities for study-specific country-level activities from study startup through conduct and study close on studies of limited complexity.

Candidates with the following experience will be considered:

• A minimum of 2 + years of leading clinical trials is required.
• Expertise in the use of study and site dashboards and reporting tools.
• Experience in study start-up.
• Comprehensive knowledge of one’s own discipline with good knowledge of other disciplines ensures that the study can meet its goals and serve as a resource for others.
• Comprehensive knowledge in managing and coordinating specific tasks and responsibilities as part of a larger study management team.
• Demonstrated clinical research experience and/or study management/startup project manager experience.
• Demonstrated experience in managing country-level operational activities and/or vendors.
• Experience in study and quality management.
• Experience working in a matrix management environment.
• Relevant operational clinical trial experience
• Education: degree or higher – preferably science-related.
• Extensive oncology experience.

We offer exceptional financial rewards, training, and development. Expect exciting professional challenges but with a healthy work/life balance. We value your welfare just as highly as that of our patients.